Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant BPIIb allele
US6368797B1 · kind B1 · utility
4Cited by
7References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 1, 1999 |
| Grant date | Apr 9, 2002 |
| Priority date | — |
| Expiry date | Oct 1, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods for treating or identifying subjects having a neurological disease or at risk for a neurological disease by determining the presence of a variant GPIIIa and/or GPIIb allele.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.